Innate Pharma SA ADR (IPHA)
NGS · ADR · CUSIP 001033142
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for IPHA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
001033142
Market Cap
Small Cap
ADR Ratio
1:1
Previous Symbol
INNTY (changed 10/17/2019)
Business: Innate Pharma SA is a commercial-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

Company Contact

CEO
Hervé Brailly
CFO
Laure-Hélène Mercier
Investor Relations
917 499 6240 · Henry.Wheeler@innate-pharma.frr
General Email
investors@innate-pharma.com
SEC EDGAR Filings
View filings »